Tepotinib in NSCLC patients with METex14 mutations: Interim results from the phase II VISION study Meeting Abstract
| Authors: | Sakai, H.; Veillon, R.; Cortot, A. B.; Felip, E.; Mazieres, J.; Morise, M.; Sakamoto, T.; Tokito, T.; Atagi, S.; Kato, T.; Kumagai, T.; Tanaka, H.; Bruns, R.; Straub, J.; Scheele, J.; Le, X.; Paik, P. K. |
| Abstract Title: | Tepotinib in NSCLC patients with METex14 mutations: Interim results from the phase II VISION study |
| Meeting Title: | 17th Annual Meeting of the Japanese Society of Medical Oncology (JSMO) |
| Journal Title: | Annals of Oncology |
| Volume: | 30 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2019 Jul 18-20 |
| Meeting Location: | Kyoto, Japan |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-10-01 |
| Start Page: | mdz338.079 |
| Language: | English |
| ACCESSION: | WOS:000491239300146 |
| DOI: | 10.1093/annonc/mdz338.079 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: MO2-15-5 -- Appears on page vi108-vi109 of the abstract book -- Source: Wos |
